If you need to come back to us and tell Congress that the FDA's mission is to fine tune narrowly just around the approval process rather than being proactive to deal with an issue that is as massive as the management of pain, I hope you will come back to us and tell us that because I would think we would need to.
Kaine emphasizes the need for the FDA to adopt a proactive approach to pain management.
Share
More from Tim Kaine
The violence committed by Israeli settlers in the West Bank is reaching an unprecedented level, and as a result more and more Americans and Palestinians are being killed and injured. These actions – and the Israeli government’s lack of…
Commodity prices have been sort of flat. All the input prices are going up, export markets are shutting down.
Other voices in this conversation
